Kenvue Inc. Reports Decline in Net Sales but Increase in Net Income for Fiscal Periods Ending September 28, 2025

Kenvue Inc. reported its financial results for the fiscal three and nine months ended September 28, 2025, revealing a decline in net sales and a mixed performance across its business segments. For the third quarter, net sales totaled $3.764 billion, a decrease of 3.5% from $3.899 billion in the same period last year. The company attributed this decline to a combination of volume-related decreases and unfavorable value realization, particularly in its Skin Health and Beauty segment. Despite the drop in sales, Kenvue's net income increased to $398 million, up from $383 million a year earlier, reflecting a 3.9% rise.

In the nine-month period, Kenvue's net sales also fell to $11.344 billion from $11.793 billion, marking a 3.8% decrease. The company reported a significant increase in operating income, which rose to $1.879 billion compared to $1.358 billion in the prior year, driven by reduced selling, general, and administrative expenses, which decreased by 5.2%. The company’s gross profit margin improved slightly to 58.7%, up from 58.4%, despite challenges such as net input cost inflation and tariffs.

Strategically, Kenvue has been undergoing a multi-year restructuring initiative aimed at enhancing operational efficiencies and positioning the company for future growth. This initiative has resulted in increased restructuring expenses, which rose to $204 million for the nine-month period, compared to $120 million in the previous year. The company is also in the process of relocating its headquarters to a new facility in Summit, New Jersey, which is expected to be fully operational by 2026.

Kenvue's operational metrics showed a decline in customer engagement, with organic sales down 4.4% in the third quarter, primarily due to changes in shipment timing and inventory management by retailers. The company continues to face challenges in its Skin Health and Beauty segment, where net sales decreased by 3.2% due to competitive pressures and changes in consumer behavior. In response to these challenges, Kenvue is focusing on optimizing its supply chain and enhancing brand support.

Looking ahead, Kenvue has entered into a merger agreement with Kimberly-Clark Corporation, which is expected to close in the second half of 2026, pending regulatory approvals and shareholder consent. This merger is anticipated to create a combined entity with enhanced capabilities in the consumer health sector. The company remains focused on navigating current market conditions while leveraging its strategic initiatives to drive future growth.